rs17154335
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000441.2(SLC26A4):c.1826T>G(p.Val609Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00773 in 1,610,138 control chromosomes in the GnomAD database, including 800 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V609V) has been classified as Likely benign.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC26A4 | NM_000441.2 | c.1826T>G | p.Val609Gly | missense_variant | 17/21 | ENST00000644269.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1826T>G | p.Val609Gly | missense_variant | 17/21 | NM_000441.2 | P1 | ||
SLC26A4 | ENST00000480841.5 | n.675T>G | non_coding_transcript_exon_variant | 8/8 | 3 | ||||
SLC26A4 | ENST00000492030.2 | n.113T>G | non_coding_transcript_exon_variant | 2/6 | 5 | ||||
SLC26A4 | ENST00000644846.1 | c.539T>G | p.Val180Gly | missense_variant, NMD_transcript_variant | 7/10 |
Frequencies
GnomAD3 genomes ? AF: 0.0404 AC: 6155AN: 152208Hom.: 425 Cov.: 32
GnomAD3 exomes AF: 0.0107 AC: 2695AN: 250926Hom.: 171 AF XY: 0.00794 AC XY: 1076AN XY: 135582
GnomAD4 exome AF: 0.00430 AC: 6268AN: 1457812Hom.: 371 Cov.: 30 AF XY: 0.00374 AC XY: 2712AN XY: 725596
GnomAD4 genome ? AF: 0.0406 AC: 6180AN: 152326Hom.: 429 Cov.: 32 AF XY: 0.0388 AC XY: 2894AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:6
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 07, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 23, 2008 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2021 | This variant is associated with the following publications: (PMID: 20981092, 27884173, 29739340, 22116359, 15689455, 19017801, 22389666, 25262649, 23273637, 30245029, 26886089, 23280318, 19204907, 30068397, 31656273) - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 23, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Pendred syndrome Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 13, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Autosomal recessive nonsyndromic hearing loss 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 06, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at